Half-year report · HY
2689.TEDINET S100XKW2
Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥62.4bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥122.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥60.6bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥674m | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥808m | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥675m | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥824m | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥695m | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥816m | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥451m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥451m | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥648m | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥48.1bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥45.9bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥46.8bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.0bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥33.6bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥12.2bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥12.3bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥11.5bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.9bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.9bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥772m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥800m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥977m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥889m | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥687m | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥76.02 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.43 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.44 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 25.3% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.7% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.6% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥966m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥966m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥68m |
| Care Nursing Goodsreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥1.5bn |
| Care Nursing Goodsreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥1.5bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥114,000 |
| Care Nursing Goodsreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥122m |
| Medical Equipmentreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥58.9bn |
| Medical Equipmentreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥58.0bn |
| Medical Equipmentreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥900m |
| Medical Equipmentreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥555m |
| SPDreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| SPDreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| SPDreportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥66m |
| SPDreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥64m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥63.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥62.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥966m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥742m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥880m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥67m |
| Care Nursing Goodsreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Care Nursing Goodsreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥19,000 |
| Care Nursing Goodsreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥105m |
| Medical Equipmentreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥57.3bn |
| Medical Equipmentreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥56.5bn |
| Medical Equipmentreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥816m |
| Medical Equipmentreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥715m |
| SPDreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| SPDreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥2.8bn |
| SPDreportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥64m |
| SPDreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥60.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥880m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥875m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 534
| Item | Context | Value | Unit |
|---|---|---|---|
| Treasury stock | Prior1YearInstant | -551294000 | JPY |
| Treasury stock | InterimInstant | -545632000 | JPY |
| Shareholders equity | Prior1YearInstant | 11768515000 | JPY |
| Shareholders equity | InterimInstant | 11730364000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 160505000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 138025000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -4181000 | JPY |
| Foreign currency translation adjustment | InterimInstant | -23918000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 330797000 | JPY |
| Remeasurements of defined benefit plans | InterimInstant | 309433000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 487121000 | JPY |
| Valuation and translation adjustments | InterimInstant | 423540000 | JPY |
| Non controlling interests | Prior1YearInstant | － | JPY |
| Non controlling interests | InterimInstant | － | JPY |
| Net assets | Prior1YearInstant | 12255637000 | JPY |
| Net assets | InterimInstant | 12153904000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 45871212000 | JPY |
| Liabilities and net assets | InterimInstant | 48111991000 | JPY |
| Net sales | Prior1InterimDuration | 60627694000 | JPY |
| Net sales | InterimDuration | 62444669000 | JPY |
| Cost of sales | Prior1InterimDuration | 53808117000 | JPY |
| Cost of sales | InterimDuration | 55504064000 | JPY |
| Gross profit | Prior1InterimDuration | 6819577000 | JPY |
| Gross profit | InterimDuration | 6940604000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 6011456000 | JPY |
| Selling general and administrative expenses | InterimDuration | 6267005000 | JPY |
| Operating income | Prior1InterimDuration | 808120000 | JPY |
| Operating income | InterimDuration | 673599000 | JPY |
| Interest income noi | Prior1InterimDuration | 482000 | JPY |
| Interest income noi | InterimDuration | 1274000 | JPY |
| Dividends income noi | Prior1InterimDuration | 1248000 | JPY |
| Dividends income noi | InterimDuration | 1440000 | JPY |
| Insurance income noi | Prior1InterimDuration | 1939000 | JPY |
| Insurance income noi | InterimDuration | 671000 | JPY |
| Foreign exchange gains noi | Prior1InterimDuration | 15594000 | JPY |
| Foreign exchange gains noi | InterimDuration | 21651000 | JPY |
| Gain on investments in partnership noi | Prior1InterimDuration | 6394000 | JPY |
| Gain on investments in partnership noi | InterimDuration | － | JPY |
| Commission fee noi | Prior1InterimDuration | 451000 | JPY |
| Commission fee noi | InterimDuration | 673000 | JPY |
| Electricity sale income noi | Prior1InterimDuration | 4188000 | JPY |
| Electricity sale income noi | InterimDuration | 4805000 | JPY |
| Subsidy income noi bounty | Prior1InterimDuration | 2179000 | JPY |
| Subsidy income noi bounty | InterimDuration | 851000 | JPY |
| Other noi | Prior1InterimDuration | 5154000 | JPY |
| Other noi | InterimDuration | 5707000 | JPY |
| Non operating income | Prior1InterimDuration | 37632000 | JPY |
| Non operating income | InterimDuration | 37075000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 16189000 | JPY |
| Interest expenses noe | InterimDuration | 27006000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |